Search research articles
Contact Us
Filters
Showing results (201-210 of 402) with videos related to
Page
of 41
Sort By:
Blood Cancer Journal
|
June 28, 2022
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders
Saurabh Zanwar, Jithma P Abeykoon, Surendra Dasari, et al.
Leukemia & Lymphoma
|
July 25, 2022
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States
Karan L Chohan, Jithma P Abeykoon, Stephen M Ansell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 19, 2015
Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting
Titilayo O Adegboyega, Jeffrey Landercasper, Jared H Linebarger, et al.
Haematologica
|
May 25, 2019
Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by <i>MAP2K1</i>
Jérôme Razanamahery, Eli L Diamond, Fleur Cohen-Aubart, et al.
The Oncologist
|
May 31, 2022
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience
Gaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.
American Journal of Hematology
|
June 14, 2020
A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United States
Gordon J Ruan, Caleb J Smith, Courtney Day, et al.
American Journal of Hematology
|
July 28, 2015
Outcomes of primary refractory multiple myeloma and the impact of novel therapies
Neil Majithia, S Vincent Rajkumar, Martha Q Lacy, et al.
The Oncologist
|
September 28, 2020
Efficacy of BRAF-Inhibitor Therapy in BRAF<sup>V600E</sup> -Mutated Adult Langerhans Cell Histiocytosis
Antonious Z Hazim, Gordon J Ruan, Aishwarya Ravindran, et al.
Mayo Clinic Proceedings
|
September 2, 2019
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease
Gaurav Goyal, Jason R Young, Matthew J Koster, et al.
American Journal of Hematology
|
July 7, 2015
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma
Moritz Binder, S Vincent Rajkumar, Morie A Gertz, et al.
Page
of 41
Search research articles
Search
Showing results (201-210 of 402) with videos related to
Sort By:
Page
of 41
Blood Cancer Journal
|
June 28, 2022
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders
Saurabh Zanwar, Jithma P Abeykoon, Surendra Dasari, et al.
Leukemia & Lymphoma
|
July 25, 2022
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States
Karan L Chohan, Jithma P Abeykoon, Stephen M Ansell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 19, 2015
Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting
Titilayo O Adegboyega, Jeffrey Landercasper, Jared H Linebarger, et al.
Haematologica
|
May 25, 2019
Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by <i>MAP2K1</i>
Jérôme Razanamahery, Eli L Diamond, Fleur Cohen-Aubart, et al.
The Oncologist
|
May 31, 2022
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience
Gaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.
American Journal of Hematology
|
June 14, 2020
A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United States
Gordon J Ruan, Caleb J Smith, Courtney Day, et al.
American Journal of Hematology
|
July 28, 2015
Outcomes of primary refractory multiple myeloma and the impact of novel therapies
Neil Majithia, S Vincent Rajkumar, Martha Q Lacy, et al.
The Oncologist
|
September 28, 2020
Efficacy of BRAF-Inhibitor Therapy in BRAF<sup>V600E</sup> -Mutated Adult Langerhans Cell Histiocytosis
Antonious Z Hazim, Gordon J Ruan, Aishwarya Ravindran, et al.
Mayo Clinic Proceedings
|
September 2, 2019
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease
Gaurav Goyal, Jason R Young, Matthew J Koster, et al.
American Journal of Hematology
|
July 7, 2015
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma
Moritz Binder, S Vincent Rajkumar, Morie A Gertz, et al.
Page
of 41